Discovery of Potent N-Ethylurea Pyrazole Derivatives as Dual Inhibitors of Trypanosoma brucei and Trypanosoma cruzi | Zendy

Swapna Varghese | Zendy; Raphaël Rahmani | Zendy; Stephanie Russell | Zendy; Girdhar Singh Deora | Zendy; Lori Ferrins | Zendy; Arthur Toynton | Zendy; Amy Jones | Zendy; Melissa L. Sykes | Zendy; Albane Kessler | Zendy; Amanda G. Eufrásio | Zendy; Artur T. Cordeiro | Zendy; Julian Sherman | Zendy; Ana Rodrı́guez | Zendy; Vicky M. Avery | Zendy; Matthew Piggott | Zendy; Jonathan B. Baell | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Discovery of Potent N-Ethylurea Pyrazole Derivatives as Dual Inhibitors of Trypanosoma brucei and Trypanosoma cruzi

Author(s) -

Swapna Varghese,

Raphaël Rahmani,

Stephanie Russell,

Girdhar Singh Deora,

Lori Ferrins,

Arthur Toynton,

Amy Jones,

Melissa L. Sykes,

Albane Kessler,

Amanda G. Eufrásio,

Artur T. Cordeiro,

Julian Sherman,

Ana Rodrı́guez,

Vicky M. Avery,

Matthew Piggott,

Jonathan B. Baell

Publication year - 2019

Publication title -

acs medicinal chemistry letters

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.065

H-Index - 66

ISSN - 1948-5875

DOI - 10.1021/acsmedchemlett.9b00218

Subject(s) - trypanosoma brucei , trypanosoma cruzi , chagas disease , parasitemia , african trypanosomiasis , trypanocidal agent , pharmacology , ic50 , trypanosomiasis , kinetoplastida , biology , chemistry , in vitro , virology , malaria , immunology , biochemistry , parasite hosting , plasmodium falciparum , world wide web , gene , computer science

Trypanosoma brucei ( T. brucei ) and Trypanosoma cruzi ( T. cruzi ) are causative agents of parasitic diseases known as human African trypanosomiasis and Chagas disease, respectively. Together, these diseases affect 68 million people around the world. Current treatments are unsatisfactory, frequently associated with intolerable side-effects, and generally inadequate in treating all stages of disease. In this paper, we report the discovery of N -ethylurea pyrazoles that potently and selectively inhibit the viability of T. brucei and T. cruzi . Sharp and logical SAR led to the identification of 54 as the best compound, with an in vitro IC 50 of 9 nM and 16 nM against T. b. brucei and T. cruzi , respectively. Compound 54 demonstrates favorable physicochemical properties and was efficacious in a murine model of Chagas disease, leading to undetectable parasitemia within 6 days when CYP metabolism was inhibited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search